Sclerosis

Fighting Multiple Sclerosis One Shirt at a Time

Simply Shirts Launches Designer Line to Benefit MS Foundation Denver, CO (PRWEB) July 1, 2009 -- The Multiple Sclerosis Foundation has a new ally in its fight against MS, the debilitating disease that afflicts over 2.5 million people the world over. Multiple sclerosis ...

Aurora Physician Recognized for Multiple Sclerosis Care

MILWAUKEE, June 17 /PRNewswire/ -- Today the National Multiple Sclerosis Society - Wisconsin Chapter recognized Aurora neurologist Bhupendra Khatri, M.D., with its 2009 Physician Appreciation Award. The recognition commends Dr. Khatri for his service to people living with multiple sclerosis and hi...

New Study Finds 1 in 4 Multiple Sclerosis Patients With High Out-of-Pocket Costs Not Filling Prescriptions

Avoiding medications may adversely affect patient care and increase health care costs ST. PAUL, Minn., June 17 /PRNewswire/ -- One in four multiple sclerosis (MS) patients are declining to fill their prescriptions likely due to high out-of-pocket costs, according to new research conducted by ...

Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking?

- New national survey reveals insights on treatment of disease, psychosocial burden, and delays in starting treatment ROCKLAND, Mass. and NEW YORK, May 27 /PRNewswire/ -- The National Multiple Sclerosis (MS) Society, in collaboration with EMD Serono, today released findings from a nationwide ...

Launch of Highly Anticipated Oral Agents and Increasing Use of Current and Emerging Injectable Drugs Will Drive the Multiple Sclerosis Drug Market to Nearly $10 Billion in 2018

Emerging Novel Oral Therapies Will Garner 29 Percent of the Total Market in 2018, According to a New Report from Decision Resources WALTHAM, Mass., May 26 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds...

New Source of Information on Multiple Sclerosis Medications

NeedyMeds.org and the National Multiple Sclerosis Society announce a new source of information on multiple sclerosis medications and the financial help available for those living with the disease. (Vocus) May 21, 2009 -- NeedyMeds, a national nonprofit, added a new re...

More>>

Sclerosis in Medical Technology

Clay Walker's Band Against MS Foundation Donates $150,000 To Support Multiple Sclerosis Research

NASHVILLE, Tenn., July 6 /PRNewswire/ -- A Pebble Beach golf tournament pays off big for researchers looking for a cure for multiple sclerosis. The researchers took home the top prize: a $150,000 contribution from multi-platinum recording artist Clay Walker and the non-profit Band Against MS (BA...

Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line

Only 39 Percent of Newly Diagnosed Patients Receive a Drug Within One Year of Their First Diagnosis, According to a New Report from Decision Resources WALTHAM, Mass., April 15 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceut...

Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance

SAN DIEGO, Feb. 24 /PRNewswire/ -- Ambrx Inc, and Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced a global strategic collaboration to develop and commercialize Ambrx's ARX424 preclinical product candidate for the treatment of multiple sclerosis. ARX424 was created by A...

Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS)

SWARTZ CREEK, Mich., Oct. 10 /PRNewswire/ -- Diplomat Specialty Pharmacy announced today that Teva Neuroscience has selected Diplomat Specialty Pharmacy to be one of only three sites to participate in a large scale, national Therapy Optimization Study for Multiple Sclerosis (TOP MS). The goa...

Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)

SB-509 to be Evaluated in Repeat-Dosing Study in Subjects with ALS RICHMOND, Calif., Sept. 3 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today that it has opened a Phase 2 clinical trial (SB-509-801) to evaluate its drug, SB-509, in subjects with ALS, a pr...

Peptimmune Initiates Phase Ib Study of PI-2301 in Multiple Sclerosis Patients and Presentation at BIO 2008

CAMBRIDGE, Mass., June 17 /PRNewswire/ -- Peptimmune, Inc. a privately held biotechnology company, announced that physicians have treated the first participant in a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary...

More>>

Sclerosis in Medical Products

Multiple Sclerosis Panel

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

Cochrane Reviews in Multiple Sclerosis

Description: Cochrane Reviews enable all those involved with healthcare decisions to keep up to date with the very latest evidence in their field of interest - a challenge which becomes harder each year as the volume of evidence increases. Cochrane Reviews solve this problem by delivering the best single source...
Company:Skyscape, Inc.

Sclerosis in Medical Definition

Proteopathy

...pathies (multiple) Microtubule-associated protein tau Frontotemporal lobar degeneration (FTLD) (Ubi+, Tau-) TDP-43 Amyotrophic lateral sclerosis (ALS) Superoxide dismutase, TDP-43 Huntington's disease and other triplet repeat disorders (multiple) Proteins with tandem glutamine expansi...

Swank Multiple Sclerosis Diet

... Dr Swank The Swank Multiple sclerosis Diet is a low saturated fat diet for the management of Multiple sclerosis championed by Dr. Roy L. Swank , since 1948 . ... External links Swank Diet Site Multiple sclerosis The Lancet Saturated Fat ...

Sclerosis in Medical Dictionary

Sclerosis

Multiple sclerosis is an autoimmune disease in which the body's immune response attacks a person's central nervous system, leading to demyelination. Disease onset usually occurs in young adults, and it is more common in... Sclerosis or sclerotization is a hardening of tissue...

Tuberous sclerosis

Tuberous sclerosis or tuberous sclerosis complex (TSC) is a rare, multi-system genetic disease that causes benign tumours to grow in the brain and on other vital organs such as the kidneys, heart, eyes, lungs, and skin. A... Fact sheet from the National Institute of Neurological D...

Systemic sclerosis

Systemic sclerosis ". Best practice & research. ... "Preliminary criteria for the classification of systemic sclerosis (scleroderma) ... Characteristics of systemic sclerosis include essential ... Systemic sclerosis is ... However, systemic sclerosis is...

Multiple Sclerosis

Extensive information about MS, including treatment options, current research, and local MS chapters. Information resources featuring symptoms, stages, diagnoses, and treatments for multiple sclerosis affecting the brain and the spinal cord. Explains what multiple sclerosis is, wh...

Amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis is a form of motor neuron disease. ALS, sometimes called Maladie de Charcot, is a progressive, fatal, neurodegenerative disease caused by the degeneration of motor neurons, the nerve cells in the central nervous system that control... Amyotrophic l...

Spasticity

... Hospital has a dedicated team of experienced surgeons and ... Multiple sclerosis Encyclopaedia - spasticity ... Cannabinoids might reduce spasticity in multiple sclerosis. Treatment of Spasticity in Multiple sclerosis ... ...

More>>

Sclerosis in Biological News

Multiple sclerosis research charges ahead with new mouse model of disease

November 6, 2008, Cambridge, UK A new study highlights the role of a charge-switching enzyme in nervous system deficits characteristic of multiple sclerosis and other related neurological illness. Multiple sclerosis (MS) is one of several diseases in which myelin the insulator for electrica...

Potential new target for multiple sclerosis therapy

Researchers demonstrate both genetic and pharmaceutical evidence for the role of a protein called collagenase-2 in the development of multiple sclerosis (MS), providing a potential new way to combat this debilitating disease. Collagenase-2 is a member of a protein family called matrix metallop...

Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone

A group of Israeli scientists from the Technion Israel Institute of Technology, the Weizmann Institute of Science and Teva Pharmaceutical Industries have recently identified genes responsible for the positive response of many multiple sclerosis patients to the drug Copaxone®. These findings m...

Tracking down the causes of multiple sclerosis

This release is available in German . Over 100,000 people suffer from multiple sclerosis in Germany alone. Despite intensive research, the factors that trigger the disease and influence its progress remain unclear. Scientists from the Max Planck Institute of Neurobiology in Martinsried an...

UMMS researchers isolate first 'neuroprotective' gene in patients with amyotrophic lateral sclerosis

WORCESTER, Mass. A genetic variant that substantially improves survival of individuals with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been indentified by a consortium of researchers led by John Landers, PhD, Associate Professor of Neurology and Robert Brown, MD...

'Buckyballs' to treat multiple sclerosis

If you're of a certain age, you'll remember Buckminster Fuller's distinctive "geodesic domes" soccer-ball-shaped structures that the late futurist envisioned as ideal human domiciles. Tel Aviv University chemists remember them too and are now putting them to use in the treatment of multiple scle...

More>>

Sclerosis in Biological Technology

BioMS Medical's pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board

Toronto Stock Exchange Symbol: MS EDMONTON, April 21 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) for the Company's pivotal phase III MAESTRO-01...

BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board

Toronto Stock Exchange Symbol: MS EDMONTON, April 14 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) for the Company's U.S. pivotal phase III MAEST...

Bolder BioTechnology Receives $1.6 million NIH Grant to Continue Development of Multiple Sclerosis Drug

BOULDER, Colo., Oct. 15 /PRNewswire/ -- Bolder BioTechnology, Inc. announced today that it has been awarded a $1.6 million Phase II Continuing Renewal Small Business Innovation Research (SBIR) grant, entitled "Long-Acting Beta Interferon for Multiple Sclerosis", from the National Institute of ...

BioMS Medical's relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board

Toronto Stock Exchange Symbol: MS EDMONTON, Oct. 6 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) for the Company's phase II MINDSET-01 trial of ...

BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board

Toronto Stock Exchange Symbol: MS EDMONTON, Oct. 3 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) for the Company's U.S. pivotal phase III MAESTR...

Expert Neurology Panel Weighs Impact of New Reports of PML in Multiple Sclerosis Patients on Tysabri

SCOTTSDALE, Ariz., Aug. 20 /PRNewswire/ -- MedPredict, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for pharma and biotech companies with a stake in the market for multiple sclerosis (MS) thera...

Sclerosis in Biological Products

Rabbit Anti-Human ALS2CR2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.

Description:... amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 2...
Company:Proteintech Group, Inc.

Mouse Anti-Human ALS2CR8 Polyclonal Antibody, Unconjugated from Novus Biologicals

Description:... Mouse polyclonal antibody to ALS2CR8 - amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8...
Company:Novus Biologicals

Sclerosis in Biological Definition

Immune system

...isorders, particularly autoimmune disorders such as lupus erythematosus , type I diabetes (sometimes called "juvenile onset diabetes"), multiple sclerosis , psoriasis , and rheumatoid arthritis . In these the immune system fails to properly distinguish between self and non-self and attacks a part of th...

Magnetic resonance imaging

...but edematous tissues remain bright. This sequence, in particular, is currently the most sensitive way to evaluate the brain for changes of multiple sclerosis . The typical MRI examination typically consists of 5-20 sequences, each of which are chosen to provide a particular type of information about the s...

Neuron

...he myelin sheath in peripheral nerves normally runs along the axon in sections about 1 mm long, punctuated by unsheathed nodes of Ranvier . Multiple sclerosis is a neurological disorder which results from abnormal demyelination of peripheral nerves. Neurons with demyelinated axons do not conduct electrical...

Sclerosis in Biological Dictionary

Resting potential

...ons are concentrated outside the ... This cell is maintaining the resting potential . Which membrane protein is responsible for ... Multiple sclerosis Encyclopaedia - resting potential ... The resting potential is a state of disequillibrium where the surrounding ... Undergraduate Neurobiol...

Myelin

...tive research foundation focusing on developing drug therapies for multiple sclerosis patients. Brief and Straightforward Guide: What is Myelin ? ... Myelin...rves and permits the rapid transmission of nerve impulses. ... Multiple sclerosis Encyclopaedia - myelin ... Myelin considerably increases the speed that...

Multiple alleles

.... ... significance and effect size of associations between alleles and ... alleles associated with multiple ... risk alleles for multiple sclerosis in a ... MULTIPLE ALLELES AND BLOOD TYPES ... inheritance patterns can be explained only on the basis of multiple alleles . Multiple al...

Maternal effect

...sights that ... Remember the maternal -grandsire effect , and wait a generation. ... The origin of the possible maternal effect in multiple sclerosis is unknown, but ... That there is a maternal effect at all is ... Effect of estrogen on maternal behaviour after hysterectomy + ovariecto...

Leukocytes

...- New and used books like Immunophenotyping of Blood and Bone Marrow Leukocytes Application to the Determination of Immune Status and... Multiple sclerosis Encyclopaedia - leukocytes ... The role of leukocytes is to fight infection by destroying the bacteria, viruses ... White blood cell summary ...

Lichen

...... Lichen will be playing as well as friends and family. ... Lichen sclerosis Facts plus the Latest News on Lichen sclerosis Treatments - HealthNewsflash ... What Kind of Doctor Treats Lichen Sclero...